A new study has revealed for the first time, that stem cells could reverse Type 2 diabetes too.
Earlier it had been revealed by UBC, that stem cells could reverse Type 1 diabetes in mice. Now, the research conducted by scientists at University of British Columbia and BetaLogics, part of Janssen Research and Development, LLC, has found how Type 2 diabetes could be effectively cured with a combination of specially-cultured stem cells and conventional diabetes drugs.
Type 2 diabetes usually occurs in adulthood, accounting for more than 90 per cent of diabetes cases, often due to poor diet, lack of exercise and obesity.
The experiment was conducted by Timothy Kieffer, a professor in the department of cellular and physiological sciences, and scientists from BetaLogics, on mice put on a high-fat and calorie diet, by stimulating them with Type 2 diabetes, for several weeks. Then pancreatic-like cells that had been grown from human cells were surgically implanted in the mice.
Mice that had received a combination of the cells with one of three diabetes drugs became glucose tolerant, whereas mice stimulated with Type 2 diabetes, stimulated with drugs and not the transplants remained glucose-intolerant.
An important observation was that, mice were able to reduce spikes in blood sugar levels, those spikes that are responsible to cause damage and increase risk for blindness, heart attack and kidney failure.
Another unexpected result of the experiment was that the mice had turned to a normal weight, same as was of a healthy control group that had been kept on a low-fat diet.
The results have been published in Stem Cell Reports.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
